- Kaiser Permanente names SVP, Fresno service area manager
- Nebraska hospital CEO resigns amid allegations of $38K in improper spending
- Northwell’s direct contracting business wants to ‘link up’ with other health systems
- PDS Health among 1st to deploy Epic-integrated AI platform
- CommonSpirit’s 5 targets for judging payer prior auth reform — and its Humana milestone
- LifeBridge names division president
- Private equity struggles in healthcare amid mounting pressures: 5 notes for dentistry
- Who’s actually winning the fight for ASC ownership?
- Why some ASCs are buying their own anesthesia groups
- Hospital Sisters Health System names chief technology officer
- Top Medicare Advantage plans for member satisfaction in 2026: JD Power
- How a 12-hospital system saved millions with an inventory overhaul
- Corporate medicine is burning out 90% of employed physicians: 10 survey findings
- HCA Florida hospital names assistant CFO
- GE HealthCare taps new CFO
- 6-property outpatient portfolio acquired
- Patients deserve every evidence-based option for mental healthcare
- 10 anesthesia controversies in 2026
- The $314K cost of employing a physician
- Who’s driving physician M&A in 2026? 5 deals to know
- 5 ways insurers are undercutting anesthesia payments: ASA
- Prior GLP-1 use doesn’t affect bariatric surgery results: 6 things to know
- Statement on Regulation Crypto Assets: Fit-for-purpose Exemptions for Crypto Market Innovation
- Filling the Regulatory Tank: Regulation Crypto Assets Proposing Release
- Statement on Regulation Crypto Assets
- Dental therapy program enrollment up 533% in 5 years
- Dental assisting program enrollment down 5.2% in 5 years
- Dental hygiene program enrollment up 15% in 5 years
- Surgery Partners ditches its $200M M&A target in favor of de novo growth: 5 things to know
- The dental specialties DSOs will prioritize next
- Statement on Commencement of Appointment Process for Public Company Accounting Oversight Board Seat
- Dental school enrollment in the 10 states with the most dental shortage areas
- How To Protect Yourself During Wildfire Season
- Ballmer Institute lands $125M to expand child behavioral health training nationwide
- Judge weighs whether man charged with killing dentist can act as own attorney
- FDA Seeks Public Feedback to Inform Regulatory Approach for Generative AI-Enabled Medical Devices
- Included Health to offer Carrum specialty care for alternative plan members
- 52 behavioral health executive moves to know
- Hospital performance improves in June, but lags 2025
- University of Toledo gets nearly $2M to support behavioral health workforce
- CTA reporting requirements eliminated for most dental practices: 5 things to know
- National Alliance on Mental Illness names chief medical officer
- Pennsylvania opens 24/7 behavioral health crisis center
- Cyber criminals target DSOs, dental groups: 3 updates
- OpenAI boosts mental health safeguards for teens
- UnitedHealthcare expands behavioral coaching to 13 million members
- Kindergarten Vaccine Exemptions Hit Record High, New CDC Data Shows
- Loneliness Is A Health Crisis, But Doctors Alone Can't Cure It, Analysis Argues
- Ousted OHSU Healthcare CEO files lawsuit alleging wrongful termination, discrimination
- JD Power: Member satisfaction with Medicare Advantage plans continues to slide
- AMA applauds updated CMS prior authorization reporting guidance
- Constipation In Space: A New Study Provides Answers
- Social Media Beauty Trends May Up Teens' Exposure To Hormone-Disrupting Chemicals
- HIPAA-compliant marketing platform Ours Privacy lands $15M amid growing pixel concerns
- Pharma commercialization partner Valeris brings in new strategy chief
- Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS’ global test
- CSL shares up 17% as immunoglobulin boost points to signs of recovery
- R1 acquiring Humata Health to bolster AI-powered prior authorizations
- Revance hires Janelle Wichmann as chief marketing officer of skincare unit
- CMI adopts orphan drug field with dedicated center of excellence
- Waist Size Is Accurate Way To Gauge Unhealthy Excess Weight, Study Says
- Panel Offers First Guidelines For Using E-Cigarettes To Help Smokers Quit
- Celcuity keeps cool amid questions about Revtorpyk launch timing
- Newsom Promotes Affordable Insulin, But California's Generic Label Off To A Slow Start
- What Geriatric Emergency Departments Do Differently
- Drive for Nuclear Power Boosts Uranium Industry — And Tribal Health Concerns in Southwest
- Rural primary care company Hopscotch clinches $53M to expand beyond NC
- Eurofins expands operations to meet growing high-potency API demand
- 24 new behavioral health projects to know
- Four health systems, including Ochsner and Denver Health, go live with Epic's real-time prior authorization checks
- 8 new psychiatric residency programs to know
- DocGo agrees to acquire virtual care provider Hicuity Health, assumes $52M debt
- Papa, eternalHealth expand partnership around Plus platform
- Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
- As healthcare costs weigh on patients, states could play a bigger role, report finds
- Jalapeño Recalls Keep Growing As Salmonella Outbreak Investigation Continues
- Music Streaming Linked To Rise In Traffic Deaths
- EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu
- Quanovate takes back marketing claims for Mira fertility wand after P&G challenge
- Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition
- Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup
- Quartz Countertop Workers Are Falling Prey To Lung Disease
- Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
- Epic faces Federal Trade Commission antitrust investigation, Reuters reports
- Innovaccer, Mastek ink strategic partnership to scale agentic AI in healthcare globally
- Sandoz strikes $322M biosimilars deal with Shanghai Henlius
- Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication
- Many Smokers Unaware Of Heart, Brain Risks Of Smoking
- Tylenol, Other Medications Fuel Spike In Liver Damage Cases, Poison Center Data Says
- AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure
- My Husband Was Kicked Out Of Hospice For Dying Too Slowly
- Tadalafil (Cialis), Used for BPH and ED, Might Increase Glaucoma Risk, Study Says
- Kennedy’s Quiet Hunt for Autism Culprits Stalls as Trump Orders Baseless Changes to Childhood Shots
- Newsom Promotes Affordable Insulin, but California’s Generic Label Off to a Slow Start
- Inside agency view: Real Chemistry’s Frank Mazzola on audience nuance and rewarding creativity
- Abridge expands AI decision support to more clinicians in bid to become healthcare's copilot
- Danish politicians call out Eli Lilly obesity campaign
- Universal Health Services closes $835M Talkspace acquisition
- Gounder Brings Clarity to Egg Freezing, AI Virus Creation, and New Trump Vaccine Order
- States Enact Emergency Orders On Kratom While Awaiting Federal Rules
- Study examines how ICHRA adoption could help stabilize ACA risk pools
- Winter Is Coming: How Vaccines Help Protect Against Respiratory Illness
- Screen Time Is Not All Bad For Kids' Brains
- Processed Foods Linked To Prostate Cancer Risk
- Updated Statement Regarding the Division of Corporation Finance’s Role in the Exchange Act Rule 14a-8 Process
- It's BMS vs. Celgene investors once more after US appeals court revives lawsuit
- Industry Voices—AI should help cancer patients survive the healthcare system
- Tavneos trial flagged for 'serious breaches' of protocol as EU regulators dissect market withdrawal decision
- Sleep Disturbances Linked To Genetic Alzheimer's Risk
- Pre-K Sets Kids Up For School Success, Study Says
- Expect Other Seniors To Act Their Age? Then Expect Problems With Your Own Memory, Study Says
- A genomics library for the AI era
- BMS bags first FDA approval for CELMoD franchise with Zenbexus multiple myeloma nod
- People With Disabilities Say Medicaid Income Limits Stifle Career Advancement
- Trump Team’s Use of Arcane Budget Rule Threatens Medicaid Coverage
- My Husband Was Kicked Out of Hospice for Dying Too Slowly
- Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve
- Rare Bacteria In Coastal Waters Has Killed 7 This Summer
- It's crunch time for Karyopharm as company faces potential default next month
- Socializing: A Prescription For Healthier Brain Aging
- Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
- AZ's blood pressure newcomer Baxfendy fails to meet cost-effectiveness bar, ICER says
- How consumerization is reshaping pharma marketing
- Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
- Stressed Parents Turn To Screens For Help, Study Finds
- Gambling Linked To Mental Health Problems Among College Students
- Hospitals Say They Found A Tool To Help Reduce Childbirth Risks: Wristbands
- Listen to the Latest ‘KFF Health News Minute’
- Readers Speak Out on Work Requirements, Federal Data Grab, Opioid Payback Cash
- People With Disabilities Say Medicaid’s Limits on Income Stifle Career Advancement
- FDA Wants More Information From Food Makers On New Food Chemicals
- Aspirin/Omega-3 Combo Matches Antibiotics In Treating Gum Disease, Trial Finds
- Endometriosis Linked To Higher Type 2 Diabetes Risk
- Beyond Compliance: Rethinking No Surprises Act strategy
- Tamiflu Helps Keep Severely Ill Kids Out Of The ICU, Study Finds
- 'Normal' Can Backfire During Doctor/Patient Discussions
- Experimental Pulse Oximeter Accurate Regardless Of Skin Tone, Researchers Say
- Patients Wary Of Governments, Companies Pushing AI As A Rural Healthcare Solution
- Executive Order Calls For Fewer Routine Childhood Vaccines, Doctors Push Back
- Real-World Performance Of Alzheimer's Drug, Leqembi, Matches Trial Data, Study Finds
- Study Finds Undisclosed Chemicals In Most Personal Care Products
- Chairman Paul S. Atkins Letter to Robert Walley, Chair, CAT NMS Plan Operating Committee
- What 524B and QMSR Change About Medical Device Risk
- Taking Lean Manufacturing to the Next Level
- Why Few MedTech Sales Teams Are Using AI Where It Matters Most
- Why Organizations Miss Emerging Product Risk: Understanding the engineering mechanisms that remain hidden long before complaint trends become visible
- Update on the SEC’s Work Toward Treasury Clearing Implementation [August 2026]
- The Interface is the Risk: A MedTech Blueprint for AI and System Integration
- Restoring Regulatory Clarity: Statement on Technical Amendments to Rule 0‑1(a)(7)
- Beyond the Status Report: Using LLMs to Reveal the True State of SaMD Development
Michigan healthcare freedom community forum
Robert F. Kennedy, Jr. was excoriated by Democratic Senators during nomination hearings before the Senate Finance & the Health, Education, Labor and Pensions Committees. Curiously, RFK, Jr. happens to still be a Democrat. One possible reason for his abuse at the hand of his fellow Democrats would be the Democratic Senators consider him an apostate for participating in President Trump's campaign and victory. The other possibility is the Democratic Senators are owned body and soul by Big Pharma and other anti MAHA (Make America Healthy Again) interests.
The Democratic propagandists in the main stream media are not covering this story because Champagne Socialist Bernie Sanders and Heap Big Faker Elizabeth "Pocahontas" Warren seem to be the most thoroughly compromised, but the story is getting some traction in alternative media:
RFK Jr. Exposes Big Pharma-Backed Senators During His Confirmation Hearing
By RVM News Staff - January 31, 2025Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services (HHS) sparked contentious debate in the Senate this week, bringing renewed attention to the influence of pharmaceutical and health industry donations on lawmakers.
During a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on Thursday, Kennedy defended his record against critics while senators questioning him found their own financial ties to the healthcare industry under scrutiny.
Senate HELP Committee Chair Bill Cassidy (R-LA) questioned Kennedy’s past statements on vaccines, including those related to measles and Hepatitis B.
While expressing concerns over Kennedy’s views, Cassidy acknowledged the nominee’s broad popular support.
“My responsibility is to learn, to try to understand if you can be trusted to support the best public health,” Cassidy said.
“A worthy movement called MAHA [Make America Healthy Again] to improve the health of Americans, or to undermine it, always asking for more evidence and never accepting the evidence that is there. That’s my dilemma, man. So you may be hearing from me over the weekend.”
Meanwhile, Kennedy and his supporters have pointed to the role of pharmaceutical industry donations in the confirmation process.
“Our kids are getting sicker and sicker. All of the people here who are defending this current system, and defending these pharmaceutical profits, are taking huge amounts of money from the pharmaceutical industry,” Kennedy said.
“This is not making our country healthier. It’s making our country sicker. We need to get rid of these conflicts.”
The role of industry donations in the confirmation process has drawn heightened attention, particularly regarding members of the Senate Finance Committee and the HELP Committee.
The watchdog group OpenSecrets has tracked contributions from pharmaceutical companies, health professionals, and related industries to committee members over the past five years.
Senate Finance Committee Ranking Member Ron Wyden (D-OR) has received significant contributions from the health sector between 2019 and 2024, including $749,316 from health professionals, $652,004 from insurers, $539,242 from health services and HMOs, and $502,063 from the pharmaceutical industry.
His top donors include Blue Cross/Blue Shield and Centene Corporation.
Cassidy, who expressed uncertainty over Kennedy’s confirmation, received $1,623,298 from health professionals and $996,737 from the pharmaceutical industry from 2019 to 2025, with Ochsner Health System as one of his top donors.
Even senators known for their criticism of the pharmaceutical industry have come under scrutiny.
Sen. Elizabeth Warren (D-MA) raised concerns that Kennedy’s lawsuits against pharmaceutical companies could financially damage vaccine manufacturers.
However, Warren has received $498,074 from health professionals, $126,056 from the pharmaceutical industry, and $109,065 from hospitals and nursing homes over the same period.
Sen. Bernie Sanders (I-VT), a longtime critic of corporate influence, has received $115,690 from the pharmaceutical industry and $159,233 from the food and beverage industry.
Sen. Bernie Sanders speaks at Erie High School in support of the Harris/Walz presidential campaign in Erie on Oct. 26, 2024.
During Kennedy’s testimony, Sanders was challenged on the $1,417,633 in contributions from pharmaceutical industry employees during his 2020 presidential campaign.“The problem of corruption is not just in the federal agencies. It’s in the Congress too,” Kennedy said.
“Almost all the members of this panel, including yourself, are accepting millions of dollars from the pharmaceutical industry and protecting their interests.”
Sanders defended his contributions, stating, “I ran for president like you. I got millions and millions of contributions. They did not come from the executives, not one nickel of PAC money from the pharmaceutical industry. They came from workers.”
Beyond campaign contributions, several senators overseeing Kennedy’s confirmation hold personal financial interests in industries that could be affected by his policies.
Wyden’s spouse owns stock valued between $50,000 and $100,000 in Restaurant Brands International Inc., which owns Burger King, Popeyes, and Firehouse Subs, as well as an investment worth between $1,001 and $15,000 in Pfizer.
Sen. Susan Collins (R-ME), a member of the HELP Committee, has financial ties to multiple industries regulated by HHS.
Her spouse owns stocks valued between $15,000 and $50,000 in companies such as EcoLab Inc., The Hershey Company, Johnson & Johnson, Merck & Co., and Thermo Fisher Scientific Inc.
Sen. Mark Warner (D-VA) has between $1 million and $5 million invested in Health Velocity Capital I, LP, a hedge fund focusing on healthcare technology, along with between $250,000 and $500,000 in Health Velocity II, LP, a venture capital fund.
While many senators on both sides of the aisle remain skeptical of Kennedy’s nomination, some have voiced strong support.
Sen. Marsha Blackburn (R-TN), one of the top recipients of pharmaceutical industry contributions in 2023-2024, has endorsed Kennedy’s nomination.
“It’s time to confirm RFK Jr. as HHS Secretary. He is ready to MAHA,” Blackburn said during the Senate Finance Committee hearing.
Kennedy’s confirmation remains uncertain as senators weigh his nomination against their own industry ties, with both his critics and supporters facing public scrutiny over their financial relationships with the healthcare sector.
In the 2019-20 Congressional funding cycle, Sanders received more money from people employed in the field classified by Open Secrets as "pharmaceuticals/health products" ($1.4 million) than any other member of Congress. He also received roughly $400,000 from people employed in "pharmaceutical manufacturing."
Elizabeth Warren raked in roughly $5 million from the health industry during her presidential bid in 2020.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.























